Search

Your search keyword '"Waters AM"' showing total 244 results

Search Constraints

Start Over You searched for: Author "Waters AM" Remove constraint Author: "Waters AM"
244 results on '"Waters AM"'

Search Results

151. Developing Partnerships in the Provision of Youth Mental Health Services and Clinical Education: A School-Based Cognitive Behavioral Intervention Targeting Anxiety Symptoms in Children.

152. One session treatment for pediatric blood-injection-injury phobia: A controlled multiple baseline trial.

153. Look for good and never give up: A novel attention training treatment for childhood anxiety disorders.

154. Young Adolescents' Body Dysmorphic Symptoms: Associations with Same- and Cross-Sex Peer Teasing via Appearance-based Rejection Sensitivity.

156. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.

157. Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.

158. Intensive group-based CBT for child social phobia: a pilot study.

159. The kinetochore protein, CENPF, is mutated in human ciliopathy and microcephaly phenotypes.

160. Attention bias to emotional information in children as a function of maternal emotional disorders and maternal attention biases.

161. Reply: To PMID 23842102.

162. Delirium affects length of hospital stay after lung transplantation.

163. Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.

164. Threat Interpretation Bias in Children With Obsessive-Compulsive Disorder: Examining Maternal Influences.

165. Direction of attention bias to threat relates to differences in fear acquisition and extinction in anxious children.

166. Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children.

167. Augmenting one-session treatment of children's specific phobias with attention training to positive stimuli.

168. Context and explicit threat cue modulation of the startle reflex: preliminary evidence of distinctions between adolescents with principal fear disorders versus distress disorders.

169. The CONSENSUS study: protocol for a mixed methods study to establish which outcomes should be included in a core outcome set for oropharyngeal cancer.

170. Adversity in early and mid-adolescence is associated with elevated startle responses to safety cues in late adolescence.

171. Biased attention to threat in paediatric anxiety disorders (generalized anxiety disorder, social phobia, specific phobia, separation anxiety disorder) as a function of 'distress' versus 'fear' diagnostic categorization.

172. Normative values and predictors of retinal oxygen saturation.

173. Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.

174. Fear acquisition and extinction in offspring of mothers with anxiety and depressive disorders.

175. The interaction between FAK, MYCN, p53 and Mdm2 in neuroblastoma.

176. Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.

177. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.

178. Latest statistics on cardiovascular disease in Australia.

179. Attention training towards positive stimuli in clinically anxious children.

180. Functional gastrointestinal symptoms in children with anxiety disorders.

181. Antitumor effects of synthetic 6,7-annulated-4-substituted indole compounds in L1210 leukemic cells in vitro.

182. The relationships of child and parent factors with children's anxiety symptoms: parental anxious rearing as a mediator.

183. Cognitive biases and obsessive-compulsive symptoms in children: examining the role of maternal cognitive bias and child age.

184. A founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis.

185. Direction of threat attention bias predicts treatment outcome in anxious children receiving cognitive-behavioural therapy.

186. Elevated responding to safe conditions as a specific risk factor for anxiety versus depressive disorders: evidence from a longitudinal investigation.

187. Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment.

188. No evidence for an epidemic of stroke with the ageing of the population.

189. Notch promotes dynamin-dependent endocytosis of nephrin.

190. The Relationships of Personality and Cognitive Styles with Self-Reported Symptoms of Depression and Anxiety.

191. Ciliopathies: an expanding disease spectrum.

192. Bioactivity of synthetic 2-halo-3-aryl-4(3H)-quinazoliniminium halides in L1210 leukemia and SK-BR-3 mammary tumor cells in vitro.

193. aHUS caused by complement dysregulation: new therapies on the horizon.

194. Safety and utility of scheduled nonnarcotic analgesic medications in children undergoing craniotomy for brain tumor.

195. Synthesis and antiproliferative evaluation of 5-oxo and 5-thio derivatives of 1,4-diaryl tetrazoles.

196. Neuroticism as a common dimension in the internalizing disorders.

197. Attentional bias towards angry faces in childhood anxiety disorders.

198. The Northwestern-UCLA youth emotion project: Associations of cognitive vulnerabilities, neuroticism and gender with past diagnoses of emotional disorders in adolescents.

199. A social relations analysis of liking for and by peers: associations with gender, depression, peer perception, and worry.

200. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.

Catalog

Books, media, physical & digital resources